UCB:EBR
UCB SA
205,20 €
arrow_upward
+0,29%(+0,60) 1D
19 қаз., 17:35:15 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for UCB...
Open
205,50 €
High
206,40 €
Low
201,90 €
Mkt. cap
39,95 млрд
Avg. vol.
255,01 м.
Volume
155,65 м.
Dividend
0,49%
Quarterly dividend
0,25 €
Ex-dividend date
2026 ж. 04 мам.
P/E ratio
18,15
52-wk high
289,50 €
52-wk low
197,45 €
EPS
11,31 €
Shares outstanding
194,51 млн
No. of employees
9 мың
Open
205,50 €
High
206,40 €
Low
201,90 €
Mkt. cap
39,95 млрд
Avg. vol.
255,01 м.
Volume
155,65 м.
Dividend
0,49%
Quarterly dividend
0,25 €
Ex-dividend date
2026 ж. 04 мам.
P/E ratio
18,15
52-wk high
289,50 €
52-wk low
197,45 €
EPS
11,31 €
Shares outstanding
194,51 млн
No. of employees
9 мың
News stories
From web sources and news partners
ad-hoc-news.de
·
7 сағат бұрын
UCB stock: TD Cowen sets EUR 305.00 target for UCB stock
ad-hoc-news.de
·
12 сағат бұрын
UCB wins FDA approval for ZILBRYSQ autoinjector. UCB stock carries EUR 39.0 billion market value
ad-hoc-news.de
·
14 сағат бұрын
UCB stock pre-market at EUR 204.05: biopharma group overview
ad-hoc-news.de
·
3 күн бұрын
Deutsche Bank keeps EUR 295.00 target for UCB stock
Profile
UCB is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with revenue of €4.178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's disease, and Crohn's disease. The company's efforts are focused on treatments for severe diseases treated by specialists, particularly in the fields of central nervous system disorders, inflammatory disorders, and oncology.
Every three years, the company presents the UCB Award under the patronage of the Queen Elisabeth Medical Foundation to promote neuroscience research. The winner of this award is selected by an independent scientific committee. Wikipedia
About UCB SA
CEOJean-Christophe Tellier
Employees9 мың
Founded1928 ж. 18 қаң.
Headquarters-
SectorPharmaceutical industry
Websiteucb.com